Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Clearside Biomedical Inc | CLSD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.32 | 04:25:25 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.32 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.650101 - 2.12 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 1.32 | USD |
Clearside Biomedical Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 98.63M | 74.72M | - | 8.23M | -32.49M | -0.43 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Clearside Biomedical News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLSD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.29 | 1.39 | 1.10 | 1.25 | 298,665 | 0.03 | 2.33% |
| 1 Month | 1.77 | 1.80 | 1.10 | 1.41 | 306,798 | -0.45 | -25.42% |
| 3 Months | 1.23 | 2.12 | 1.10 | 1.55 | 377,227 | 0.09 | 7.32% |
| 6 Months | 0.82 | 2.12 | 0.650101 | 1.39 | 281,152 | 0.50 | 60.98% |
| 1 Year | 1.13 | 2.12 | 0.650101 | 1.30 | 196,509 | 0.19 | 16.81% |
| 3 Years | 2.71 | 7.73 | 0.650101 | 3.42 | 558,975 | -1.39 | -51.29% |
| 5 Years | 1.23 | 7.73 | 0.56 | 2.84 | 585,286 | 0.09 | 7.32% |
Clearside Biomedical Description
| Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision. |
